Cellebrite(NASDAQ) CLBT

Cellebrite DI Ltd. specializes in digital intelligence solutions designed for legally authorized investigations. The company offers a comprehensive platform that enables efficient gathering and analysis of digital information across various investigative scenarios.

Products and Services

• Universal Forensic Extraction Device (UFED) for accessing digital evidence
• Seeker for analyzing video footage in investigations
• OSINT Analyze for real-time examination of open-source information

Growth Outlook

• Revenue increased to $128.3 million in Q1 2026, reflecting strong demand
• Trailing twelve months (TTM) gross profit margin stands at 83.86%
• Operating income margin improved to 7.11% in Q1 2026

Financial Highlights

• Net income of $10.9 million reported in Q1 2026
• Cash and short-term investments totaled $429.1 million as of March 31, 2026
• Debt ratio remains low at 2.39%, indicating strong financial health

Cellebrite DI Ltd. operates in a critical sector, providing tools essential for law enforcement and corporate security. The company's innovative products, such as the UFED, address significant challenges in digital evidence collection, making it a key player in the digital intelligence market. Recent financial performance indicates a robust growth trajectory, with increasing revenues and improving profit margins. The strong cash position further supports potential investments in research and development, positioning the company for future expansion. With a low debt ratio, Cellebrite demonstrates financial stability, making it an attractive option for investors interested in technology and security sectors.